Biomedical R&D Folie (slide) 1 Saratin - mechanism of action vWF Platelet.

Slides:

Advertisements

Similar presentations

Kapitel 1 Folie 1 Kapitel 2 Kapitel 3 Kapitel 4. Kapitel 1 Folie 2.

Advertisements

Section 3 Thrombosis Definition: Thrombosis is the formation of a blood clot within the vascular system during life. The blood clot is adherent to the.

Hematopoeisis and Hemostasis

Cardiovascular system What makes up blood What makes up blood How blood is grouped and typed How blood is grouped and typed A simple look at how blood.

Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.

Haemostasis and NovoSeven®

HEMOSTASIS Hemostasis

Coagulation (the basics) and recombinant Factor VIIa Mechanism of Action Jerrold H. Levy, MD Emory University School of Medicine and Emory Healthcare Atlanta,

Blood Clotting Robin Gray.

Coagulation Just the basics.... Three steps Vasoconstriction Platelet plug formation Fibrin clot formation.

HEMOSTASIS – Stoppage of Blood Flow.

Pathology 430/826 Thrombosis David Lillicrap. Cardiovascular Disease 30% of all deaths in Canada 54% ischemic heart disease 20% stroke 23% heart attack.

MLAB Coagulation Keri Brophy-Martinez

Blood Course By Dr. Khidir Abdel Galil.

Blood Clotting The Coagulation Process. What is Blood? Blood is a fluid that carries nutrients, gases, and wastes through the body. The blood consists.

Chapter 14.2: White Blood Cells and Platelets. White Blood Cells (WBCs) -Also called leukocytes -Contain a nucleus and other organelles -No hemoglobin.

Blood Clots, Polymers and Strokes

Hemodynamic Disorders (Disorders of blood flow)

CH42-2 Myocardial infarction and thrombus Biological Theme Presentation MED 1 B B 廖治豪 B 趙彥豪 Instructor : 周淑娥 Guidance TA : 洪偉珊.

Antiplatelet Drugs - Principles Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.

HEMOSTASIS Primary hemostasis.

Hematopoiesis & Hemostasis

Investigating inter-domain regulation of von Willebrand factor interactions with platelets Ryan M Harrison 1, An-Yue Tu 2, Wendy E Thomas 2 1 Department.

Arrange the slides in the proper order then change the background to a color other than white to check yourself. Close without saving to return to orginal.

Nerves Smooth muscle Endothelium Platelets White cells eg neutrophils Red cells.

ANTIPLATELET DRUGS.

Unit 8 Review Chapters Cardiovascular System Review.

Platelet Structure & Function

Antiplatelet drugs Prof. Hanan Hagar Learning objectives By the end of this lecture, students should be able to to describe different classes of anti-platelet.

Positive and Negative Feedback. Positive Feedback Designed to accelerate or enhance a response that has already started Pushes systems outside of their.

Von Willebrand Disease

Prof. Abdulrahman Almotrefi

Circulatory System Vocabulary. Atrium  Upper chamber of heart.

II. Antiplatelet Drugs.

Platelets (Thrombocytes)

Venous Thromboembolism-1

HAEMOSTASIS AND THROMBOSIS Regulation of coagulation

Circulatory System Living Environment.

A. Formation of the Platelet Plug

2nd Year Medicine- Blood Module May 2008

continued on next slide

Anti-Thrombotic Review

Figure 1 Mechanism of action of caplacizumab

continued on next slide

Role of high shear rate in thrombosis

بهداشت فردي.

“Radical” model of thrombosis

Figure 1 Mechanism of thrombus formation during ST-segment

Cells into Tissues By Kevin Huyen.

Thrombosis in flowing blood

Volume 55, Issue 6, Pages (December 2011)

Flow diversion concept: placement of a high-mesh density stent (flow diverter) in the parent vessel disrupts blood flow into the aneurysm (A and B), allowing.

C1qTNF–related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen by Gerald.

by J. Evan Sadler Blood Volume 112(1):11-18 July 1, 2008

Paul A. Gurbel, and Udaya S. Tantry JCHF 2014;2:1-14

R. Clive Landis, PhD, George Asimakopoulos, Mike Poullis, Dorian O

Figure 1 Mechanisms of platelet adhesion and aggregation

Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow Brian Savage, Fanny Almus-Jacobs, Zaverio M Ruggeri

Protein kinase Cα: disease regulator and therapeutic target

Nat. Rev. Cardiol. doi: /nrcardio

Prof. Abdulrahman Almotrefi

Hexabrix Review Missy Buchanan & Jean-Philippe Barraud

Flow diversion concept: placement of a high-mesh density stent (flow diverter) in the parent vessel disrupts blood flow into the aneurysm (A and B), allowing.

The von Willebrand Factor protein showing various functional domains that have been mapped to regions of the cDNA. The von Willebrand Factor protein showing.

Hemostasis Hemostasis depends on the integrity of Blood vessels

Section B: Science update

Interaction of platelet-decorated VWF strings with leukocytes and infected red blood cells in vitro. Interaction of platelet-decorated VWF strings with.

Presentation transcript:

Biomedical R&D Folie (slide) 1 Saratin - mechanism of action vWF Platelet

Biomedical R&D Folie (slide) 2 Saratin - mechanism of action vWF Platelet

Biomedical R&D Folie (slide) 3 Saratin - mechanism of action Platelet vWF

Biomedical R&D Folie (slide) 4 Saratin - mechanism of action vWF Platelet

Biomedical R&D Folie (slide) 5 Saratin - mechanism of action Platelet vWF

Biomedical R&D Folie (slide) 6 Saratin - mechanism of action vWF Platelet

Biomedical R&D Folie (slide) 7 Saratin - mechanism of action Platelet vWF

Biomedical R&D Folie (slide) 8 Saratin - mechanism of action Platelet

Biomedical R&D Folie (slide) 9 Saratin - mechanism of action

Biomedical R&D Folie (slide) 10 Saratin - mechanism of action

Biomedical R&D Folie (slide) 11 Saratin - mechanism of action

Biomedical R&D Folie (slide) 12 Saratin - mechanism of action

Biomedical R&D Folie (slide) 13 Saratin - mechanism of action

Biomedical R&D Folie (slide) 14 Saratin - mechanism of action

Biomedical R&D Folie (slide) 15 Saratin - mechanism of action

Biomedical R&D Folie (slide) 16 Saratin - mechanism of action

Biomedical R&D Folie (slide) 17 Saratin - mechanism of action

Biomedical R&D Folie (slide) 18 Saratin - mechanism of action

Biomedical R&D Folie (slide) 19 Saratin - mechanism of action

Biomedical R&D Folie (slide) 20 Saratin - mechanism of action

Biomedical R&D Folie (slide) 21 Saratin - mechanism of action

Biomedical R&D Folie (slide) 22 Saratin - mechanism of action

Biomedical R&D Folie (slide) 23 Saratin - mechanism of action Vessel wall injury exposes collagen to elements of flowing blood.

Biomedical R&D Folie (slide) 24 Saratin - mechanism of action

Biomedical R&D Folie (slide) 25 Saratin - mechanism of action

Biomedical R&D Folie (slide) 26 Saratin - mechanism of action

Biomedical R&D Folie (slide) 27 Saratin - mechanism of action

Biomedical R&D Folie (slide) 28 Saratin - mechanism of action

Biomedical R&D Folie (slide) 29 Saratin - mechanism of action vWF A3 domain binds to collagen.

Biomedical R&D Folie (slide) 30 Saratin - mechanism of action

Biomedical R&D Folie (slide) 31 Saratin - mechanism of action

Biomedical R&D Folie (slide) 32 Saratin - mechanism of action vWF A1 domain targets GP Ib/IX/V receptor of circulating platelets, “tethering” them to the vessel wall.

Biomedical R&D Folie (slide) 33 Saratin - mechanism of action

Biomedical R&D Folie (slide) 34 Saratin - mechanism of action

Biomedical R&D Folie (slide) 35 Saratin - mechanism of action Direct collagen-platelet interactions (GP Ia/IIa, GP VI etc.) anchor and then lead to activation of the tethered platelet.

Biomedical R&D Folie (slide) 36 Saratin - mechanism of action

Biomedical R&D Folie (slide) 37 Saratin - mechanism of action

Biomedical R&D Folie (slide) 38 Saratin - mechanism of action

Biomedical R&D Folie (slide) 39 Saratin - mechanism of action

Biomedical R&D Folie (slide) 40 Saratin - mechanism of action

Biomedical R&D Folie (slide) 41 Saratin - mechanism of action

Biomedical R&D Folie (slide) 42 Saratin - mechanism of action

Biomedical R&D Folie (slide) 43 Saratin - mechanism of action

Biomedical R&D Folie (slide) 44 Saratin - mechanism of action Occlusive thrombus!

Biomedical R&D Folie (slide) 45 Saratin - mechanism of action How does saratin interfere with arterial thrombosis?

Biomedical R&D Folie (slide) 46 Saratin - mechanism of action

Biomedical R&D Folie (slide) 47 Saratin - mechanism of action

Biomedical R&D Folie (slide) 48 Saratin - mechanism of action

Biomedical R&D Folie (slide) 49 Saratin - mechanism of action

Biomedical R&D Folie (slide) 50 Saratin - mechanism of action

Biomedical R&D Folie (slide) 51 Saratin - mechanism of action S

Biomedical R&D Folie (slide) 52 Saratin - mechanism of action S S

Biomedical R&D Folie (slide) 53 Saratin - mechanism of action S S S

Biomedical R&D Folie (slide) 54 Saratin - mechanism of action S Saratin binds to collagen, preventing interaction with vWF and hence platelets. S S S

Biomedical R&D Folie (slide) 55 Saratin - mechanism of action S S S S

Biomedical R&D Folie (slide) 56 Saratin - mechanism of action S S S S

Biomedical R&D Folie (slide) 57 Saratin - mechanism of action S S S S

Biomedical R&D Folie (slide) 58 Saratin - mechanism of action S S S S

Biomedical R&D Folie (slide) 59 Saratin - mechanism of action S S S S

Biomedical R&D Folie (slide) 60 Saratin - mechanism of action S S S S

Biomedical R&D Folie (slide) 61 Saratin - mechanism of action S S S S

Biomedical R&D Folie (slide) 62 Saratin - mechanism of action S S S S

Biomedical R&D Folie (slide) 63 Saratin - mechanism of action Saratin acts as a molecular plaster, neutralising platelets BEFORE they adhere and become activated. S S S S